256 related articles for article (PubMed ID: 28614815)
1. A Case of Pulmonary Langerhans Cell Sarcoma Simultaneously Diagnosed with Cutaneous Langerhans Cell Histiocytosis Studied by Whole-Exome Sequencing.
Kim SW; Choi MK; Han HS; Song H; Koh Y; Son SM; Lee OJ; Lee JY; Lee KM; Lee KH; Kwon J
Acta Haematol; 2017; 138(1):24-30. PubMed ID: 28614815
[TBL] [Abstract][Full Text] [Related]
2. CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.
Xerri L; Adélaïde J; Popovici C; Garnier S; Guille A; Mescam-Mancini L; Laurent C; Brousset P; Coze C; Michel G; Chaffanet M; Bouabdallah R; Coso D; Bertucci F; Birnbaum D
Am J Surg Pathol; 2018 Feb; 42(2):150-159. PubMed ID: 29194093
[TBL] [Abstract][Full Text] [Related]
3. A case of Langerhans cell sarcoma on the scalp: Whole-exome sequencing reveals a role of ultraviolet in the pathogenesis.
Katsuragawa H; Yamada Y; Ishida Y; Kaku Y; Fujimoto M; Kataoka TR; Haga H
Pathol Int; 2020 Nov; 70(11):881-887. PubMed ID: 33410565
[TBL] [Abstract][Full Text] [Related]
4. BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
Tatsuno M; Shioda Y; Iwafuchi H; Yamazaki S; Iijima K; Takahashi C; Ono H; Uchida K; Okamura O; Matubayashi M; Okuyama T; Matsumoto K; Yoshioka T; Nakazawa A
Diagn Pathol; 2016 Apr; 11():39. PubMed ID: 27094161
[TBL] [Abstract][Full Text] [Related]
5. Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH.
McGinnis LM; Nybakken G; Ma L; Arber DA
Am J Surg Pathol; 2018 Jul; 42(7):885-890. PubMed ID: 29649018
[TBL] [Abstract][Full Text] [Related]
6. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.
Kansal R; Quintanilla-Martinez L; Datta V; Lopategui J; Garshfield G; Nathwani BN
Genes Chromosomes Cancer; 2013 Jan; 52(1):99-106. PubMed ID: 22996177
[TBL] [Abstract][Full Text] [Related]
7. Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis.
Nakamine H; Yamakawa M; Yoshino T; Fukumoto T; Enomoto Y; Matsumura I
J Clin Exp Hematop; 2016; 56(2):109-118. PubMed ID: 27980300
[TBL] [Abstract][Full Text] [Related]
8. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report.
Lee JS; Ko GH; Kim HC; Jang IS; Jeon KN; Lee JH
J Korean Med Sci; 2006 Jun; 21(3):577-80. PubMed ID: 16778410
[TBL] [Abstract][Full Text] [Related]
9. Squash smear cytology of Langerhans cell histiocytosis.
Nahm JH; Yoon G; Do SI; Kim HS
Int J Clin Exp Pathol; 2015; 8(7):7998-8007. PubMed ID: 26339366
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adult xanthogranuloma with a small portion of BRAF
Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
[TBL] [Abstract][Full Text] [Related]
11. From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature.
Tashakori M; Thakral B; Tang G; Khoury JD; Medeiros LJ
Ann Diagn Pathol; 2021 Jun; 52():151720. PubMed ID: 33676171
[TBL] [Abstract][Full Text] [Related]
12. Unusual presentation of Langerhans cell sarcoma as bilateral submandibular gland swelling - A rare case report.
Mohanty P; Sahoo N; Lenka A; Bhattacharyya S
Indian J Cancer; 2022; 59(1):123-127. PubMed ID: 35645054
[TBL] [Abstract][Full Text] [Related]
13. Association between clinicopathologic characteristics and BRAF
Huang H; Lu T; Sun Y; Li S; Li J; Xu K; Feng RE; Xu ZJ
Thorac Cancer; 2019 Oct; 10(10):1984-1992. PubMed ID: 31441596
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of Wilms tumor 1 and CD44 in Langerhans cell sarcoma: case series of 4 patients.
Wang CS; Chen YP; He WH; Yin J; Gao CF; Wang P; Li H; Lv XX
Medicine (Baltimore); 2015 Apr; 94(13):e636. PubMed ID: 25837753
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature.
Jülg BD; Weidner S; Mayr D
Virchows Arch; 2006 Mar; 448(3):369-74. PubMed ID: 16328350
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan.
Sasaki Y; Guo Y; Arakawa F; Miyoshi H; Yoshida N; Koga Y; Nakashima K; Kurita D; Niino D; Seto M; Ohshima K
Hematol Oncol; 2017 Sep; 35(3):329-334. PubMed ID: 27041734
[TBL] [Abstract][Full Text] [Related]
17. Langerhans Cell Sarcoma in a Chronic Myelogenous Leukemia Patient Undergoing Imatinib Mesylate Therapy: A Case Study and Review of the Literature.
Chang NY; Wang J; Wen MC; Lee FY
Int J Surg Pathol; 2014 Aug; 22(5):456-63. PubMed ID: 24008437
[TBL] [Abstract][Full Text] [Related]
18. Somatic ARAF mutations in pediatric Langerhans cell histiocytosis: clinicopathologic, genetic and functional profiling.
Liu R; Guo Y; Han L; Feng S; Cao J; Sun Y; Cao Z; Cui X
Clin Exp Med; 2023 Dec; 23(8):5269-5279. PubMed ID: 37572153
[TBL] [Abstract][Full Text] [Related]
19. Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis.
Chilosi M; Facchetti F; Caliò A; Zamò A; Brunelli M; Martignoni G; Rossi A; Montagna L; Piccoli P; Dubini A; Tironi A; Tomassetti S; Poletti V; Doglioni C
Leuk Lymphoma; 2014 Nov; 55(11):2620-6. PubMed ID: 24471909
[TBL] [Abstract][Full Text] [Related]
20. Assessment of BRAF
Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
